The global medical devices market witnessed deals worth $183 billion in 2025, an increase of 30% compared to 2024. The sector recorded deal value worth $162 billion mega-deals (defined as any deal valued at more than $1 billion), an increase of 49% compared to 2024.
Report Scope
- This report provides an overview of merger and acquisition activity globally in 2025 in Medical Devices Sector
- It identifies the themes driving most notable to deals announced in 2025 in the Medical Devices Sector
Reasons to Buy
- Companies who invest in the right themes become success stories; those who miss the big themes end up as failures. If you want to understand the themes that drive an industry, simply look at the list of recent mergers and acquisitions (M&A).
- In this report we have listed down the most notable deals in medical devices sector to make it easy for our clients to get a view of themes disrupting the sector and prepare for the future.
Table of Contents
- Executive Summary
- Review of the Medical Devices M&A Market - 2025
- Medical Devices M&A Deals Analysis by Geography - 2025
- Further Reading
- Report Authors
- Appendix 1: Deal Selection Criteria
- Appendix 2: Thematic Research Methodology
- Contact the Publisher
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Kimberly-Clark Corp
- Abbott Laboratories
- Abu Dhabi Investment Authority
- Blackstone Inc
- GIC Private Ltd
- TPG Capital LP
- Waters
- Thermo Fisher Scientific Inc
- Qualtrics LLC
- Eagle 1 Merger Sub Inc
- Thermo Fisher Scientific Inc
- Johnson & Johnson
- Patient Square Capital LP
- Kenvue Inc
- Exact Sciences Corp
- Hologic Inc
- Augusta SpinCo and BD
- Clario
- Press Ganey Associates LLC
- Inari Medical Inc
- Solventum
- Halda Therapeutics LLC
- Premier Inc
